DK2523674T3 - Sammensætninger omfattende andrographis paniculata-ekstrakter kombineret med ginkgo biloba-ekstrakter, der er kompleksbundet med phospholipider, og anvendelse deraf - Google Patents
Sammensætninger omfattende andrographis paniculata-ekstrakter kombineret med ginkgo biloba-ekstrakter, der er kompleksbundet med phospholipider, og anvendelse derafInfo
- Publication number
- DK2523674T3 DK2523674T3 DK11701027.2T DK11701027T DK2523674T3 DK 2523674 T3 DK2523674 T3 DK 2523674T3 DK 11701027 T DK11701027 T DK 11701027T DK 2523674 T3 DK2523674 T3 DK 2523674T3
- Authority
- DK
- Denmark
- Prior art keywords
- extracts
- phospholipids
- compositions
- complexed
- ginkgo biloba
- Prior art date
Links
- 244000118350 Andrographis paniculata Species 0.000 title 1
- 239000000284 extract Substances 0.000 title 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 150000003904 phospholipids Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/16—Ginkgophyta, e.g. Ginkgoaceae (Ginkgo family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/19—Acanthaceae (Acanthus family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4816—Wall or shell material
- A61K9/4825—Proteins, e.g. gelatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Alternative & Traditional Medicine (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Portable Nailing Machines And Staplers (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Cosmetics (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ITMI2010A000019A IT1397386B1 (it) | 2010-01-12 | 2010-01-12 | Composizioni a base di estratti di andrographis paniculata combinati con estratti di ginkgo biloba complessati con fosfolipidi e loro uso. |
| PCT/EP2011/050016 WO2011086007A1 (en) | 2010-01-12 | 2011-01-03 | Compositions comprising andrographics paniculata and gingko biloba extracts complexed with phospholipids |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2523674T3 true DK2523674T3 (da) | 2014-04-22 |
Family
ID=42342839
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK11701027.2T DK2523674T3 (da) | 2010-01-12 | 2011-01-03 | Sammensætninger omfattende andrographis paniculata-ekstrakter kombineret med ginkgo biloba-ekstrakter, der er kompleksbundet med phospholipider, og anvendelse deraf |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US9192636B2 (da) |
| EP (1) | EP2523674B1 (da) |
| JP (1) | JP5819852B2 (da) |
| KR (1) | KR101781113B1 (da) |
| CN (1) | CN102724989A (da) |
| AU (1) | AU2011206693B2 (da) |
| BR (1) | BR112012017080B1 (da) |
| CA (1) | CA2786780C (da) |
| CL (1) | CL2012001940A1 (da) |
| DK (1) | DK2523674T3 (da) |
| ES (1) | ES2459540T3 (da) |
| HR (1) | HRP20140553T1 (da) |
| IL (1) | IL220873A (da) |
| IT (1) | IT1397386B1 (da) |
| MX (1) | MX2012008081A (da) |
| PL (1) | PL2523674T3 (da) |
| PT (1) | PT2523674E (da) |
| RU (1) | RU2564093C2 (da) |
| SG (1) | SG182451A1 (da) |
| SI (1) | SI2523674T1 (da) |
| WO (1) | WO2011086007A1 (da) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ITMI20121570A1 (it) * | 2012-09-20 | 2014-03-21 | Indena Spa | Nuovi estratti di cynara scolimus, coffea spp. e olea europaea per il trattamento della sindrome metabolica |
| WO2014176149A1 (en) | 2013-04-22 | 2014-10-30 | Innobioscience, Llc | Treatment of alzheimer's and cognitive impairment with andrographolides |
| ITMI20130807A1 (it) * | 2013-05-16 | 2014-11-17 | Indena Spa | Combinazioni di estratti di serenoa repens e di estratti lipofili di zingiber officinalis e di echinacea angustifolia, loro uso e formulazioni che li contengono |
| CN105708748B (zh) | 2014-12-04 | 2020-06-30 | 玫琳凯有限公司 | 化妆品组合物 |
| MY176459A (en) * | 2016-05-23 | 2020-08-10 | Univ Putra Malaysia | Extract of andrographis paniculata for cognitive enhancement |
| WO2019055961A1 (en) | 2017-09-18 | 2019-03-21 | Mary Kay Inc. | COSMETIC COMPOSITIONS AND METHODS |
| CN110339190A (zh) * | 2018-04-08 | 2019-10-18 | 成都百裕制药股份有限公司 | 银杏萜内酯在制备预防或治疗多发性硬化药物中的应用 |
| CN113144043A (zh) * | 2021-04-24 | 2021-07-23 | 湖州润合医药科技有限公司 | 一种预防和改善记忆力减退和老年痴呆的组合物及其制备方法和应用 |
| CN117645589B (zh) * | 2023-12-11 | 2024-10-15 | 安徽中医药大学 | 一种穿心莲二萜内酯类化合物及其提取方法和应用 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1201149B (it) * | 1987-01-14 | 1989-01-27 | Indena Spa | Complessi di bioflavonoidi con fosfolipidi,loro preparazione,uso e composizioni farmaceutici e cosmetiche |
| JPH0353869A (ja) * | 1989-07-21 | 1991-03-07 | Nippon Oil & Fats Co Ltd | 高度不飽和脂肪酸を含む食品 |
| DE4003381A1 (de) | 1990-02-05 | 1991-08-08 | Sto Ag | Kunstharzgebundenes beschichtungsmaterial zum auftragen auf gebaeudewaende, vorzugsweise kunstharzputz |
| IT1238684B (it) | 1990-02-09 | 1993-09-01 | Indena Spa | Derivati del bilobalide,loro usi e formulazioni che li contegono |
| JPH07274826A (ja) * | 1994-03-31 | 1995-10-24 | Snow Brand Milk Prod Co Ltd | 魚臭が低減されたマグロおよび/またはカツオ眼窩脂肪 |
| JP2003169632A (ja) | 2001-12-08 | 2003-06-17 | Sapuri:Kk | 米胚芽油、卵黄油及びホスファチジルセリン含有の健康食品 |
| ITGE20020026A1 (it) * | 2002-03-25 | 2003-09-25 | Segre Silvia Perella | Composto da impiegare nel trattamento scleroterapico,nell'insufficienza venosa e nelle alterazioni del microcircolo. |
| US6572899B1 (en) | 2002-07-03 | 2003-06-03 | Vitacost.Com, Inc. | Memory loss treatment formulation |
| WO2005061684A1 (ja) * | 2003-12-22 | 2005-07-07 | Wakunaga Pharmaceutical Co., Ltd. | 油脂組成物 |
| SI1559430T1 (sl) | 2004-01-29 | 2009-08-31 | Indena Spa | Uporaba kompleksov ginkga za izboljĺ anje kognitivnih funkcij in ublaĺ˝itev duĺ evne izäśrpanosti |
| CN1921872A (zh) * | 2004-02-03 | 2007-02-28 | 智利南方大学 | 用于激活PPR-γ受体而治疗自身免疫性疾病和阿尔茨海默病的提取自穿心莲的半日花烷型二萜类组合物 |
| NZ553260A (en) * | 2004-07-19 | 2010-12-24 | Thia Medica As | Composition comprising protein material and non-oxidizable fatty acid entities |
| JP2007028921A (ja) * | 2005-07-22 | 2007-02-08 | Pyuriaporisu Labs Research Co Ltd | 機能性食物 |
| US7390512B2 (en) * | 2006-09-29 | 2008-06-24 | Jose Angel Olalde Rangel | Multiple sclerosis synergistic phyto-nutraceutical composition |
| EP2205254A1 (en) * | 2007-08-20 | 2010-07-14 | Quinn Pharmaceuticals | Method of producing plant extract formulations |
| JP2010126462A (ja) * | 2008-11-26 | 2010-06-10 | Mitsubishi Gas Chemical Co Inc | 脳機能改善用組成物および該組成物を含有する機能性食品 |
-
2010
- 2010-01-12 IT ITMI2010A000019A patent/IT1397386B1/it active
-
2011
- 2011-01-03 WO PCT/EP2011/050016 patent/WO2011086007A1/en not_active Ceased
- 2011-01-03 HR HRP20140553AT patent/HRP20140553T1/hr unknown
- 2011-01-03 SG SG2012050910A patent/SG182451A1/en unknown
- 2011-01-03 JP JP2012548385A patent/JP5819852B2/ja not_active Expired - Fee Related
- 2011-01-03 CA CA2786780A patent/CA2786780C/en active Active
- 2011-01-03 US US13/520,154 patent/US9192636B2/en not_active Expired - Fee Related
- 2011-01-03 CN CN2011800058469A patent/CN102724989A/zh active Pending
- 2011-01-03 DK DK11701027.2T patent/DK2523674T3/da active
- 2011-01-03 PT PT117010272T patent/PT2523674E/pt unknown
- 2011-01-03 MX MX2012008081A patent/MX2012008081A/es active IP Right Grant
- 2011-01-03 RU RU2012129348/15A patent/RU2564093C2/ru active
- 2011-01-03 PL PL11701027T patent/PL2523674T3/pl unknown
- 2011-01-03 KR KR1020127018068A patent/KR101781113B1/ko not_active Expired - Fee Related
- 2011-01-03 BR BR112012017080-5A patent/BR112012017080B1/pt not_active IP Right Cessation
- 2011-01-03 SI SI201130163T patent/SI2523674T1/sl unknown
- 2011-01-03 EP EP11701027.2A patent/EP2523674B1/en active Active
- 2011-01-03 AU AU2011206693A patent/AU2011206693B2/en not_active Ceased
- 2011-01-03 ES ES11701027.2T patent/ES2459540T3/es active Active
-
2012
- 2012-07-11 IL IL220873A patent/IL220873A/en active IP Right Grant
- 2012-07-11 CL CL2012001940A patent/CL2012001940A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| SG182451A1 (en) | 2012-08-30 |
| EP2523674A1 (en) | 2012-11-21 |
| AU2011206693A1 (en) | 2012-08-02 |
| AU2011206693B2 (en) | 2014-03-20 |
| IL220873A (en) | 2015-07-30 |
| ITMI20100019A1 (it) | 2011-07-13 |
| JP5819852B2 (ja) | 2015-11-24 |
| IT1397386B1 (it) | 2013-01-10 |
| PT2523674E (pt) | 2014-04-30 |
| RU2564093C2 (ru) | 2015-09-27 |
| SI2523674T1 (sl) | 2014-06-30 |
| RU2012129348A (ru) | 2014-01-20 |
| MX2012008081A (es) | 2012-07-30 |
| BR112012017080A2 (pt) | 2016-04-12 |
| BR112012017080A8 (pt) | 2016-10-04 |
| CL2012001940A1 (es) | 2012-12-07 |
| PL2523674T3 (pl) | 2014-07-31 |
| ES2459540T3 (es) | 2014-05-09 |
| WO2011086007A8 (en) | 2011-09-22 |
| JP2013517234A (ja) | 2013-05-16 |
| BR112012017080B1 (pt) | 2020-12-01 |
| HRP20140553T1 (hr) | 2014-07-18 |
| EP2523674B1 (en) | 2014-03-26 |
| US20120301560A1 (en) | 2012-11-29 |
| CA2786780A1 (en) | 2011-07-21 |
| CA2786780C (en) | 2018-02-20 |
| CN102724989A (zh) | 2012-10-10 |
| KR101781113B1 (ko) | 2017-09-22 |
| KR20120114299A (ko) | 2012-10-16 |
| US9192636B2 (en) | 2015-11-24 |
| WO2011086007A1 (en) | 2011-07-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2523674T3 (da) | Sammensætninger omfattende andrographis paniculata-ekstrakter kombineret med ginkgo biloba-ekstrakter, der er kompleksbundet med phospholipider, og anvendelse deraf | |
| IL224976A (en) | Converted history of 1h - indazole and a pharmaceutical preparation containing them | |
| IL223983A (en) | Compounds of heterocyclic benzene alkynyl, containing pharmaceutical preparations and their use | |
| BR112013011448A2 (pt) | composto, composição farnmacêutica, e, uso do composto | |
| IT1398930B1 (it) | Formulazioni farmaceutiche bistrato contenenti agonisti ed antagonisti oppioidi. | |
| IL201101A0 (en) | Methods of administering tetrahydrobiopterin associated compositions, and methods of measuring | |
| BRPI0924137A2 (pt) | composição farmacêutica sólida compreendendo amlodipina e losartan com melhor estabilidade | |
| EP2616076A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| IL224288A (en) | Derivatives of converted pyrazolamide, pharmaceutical preparations containing them and their use | |
| IT1403847B1 (it) | Composizioni farmaceutiche comprendenti rifaximina e loro uso. | |
| BR112012031226A2 (pt) | composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica | |
| BR112013013369A2 (pt) | ligante sigma, uso do mesmo e combinação de pelo menos um ligante sigma | |
| BR112013007022A2 (pt) | uso de estearato de magnésio, formulação farmacêutica e inalador de pó seco | |
| EP2474522A4 (en) | AGOME ELITE AND PHARMACEUTICAL COMPOSITIONS THEREOF | |
| BRPI0918206A2 (pt) | derivados de animoéster e composição medicinal destes | |
| PT2568980E (pt) | Formulações parasiticidas injectáveis de levamisole e lactonas macrocíclicas | |
| BR112012000383A2 (pt) | composições farmacêuticas e formas sólidas | |
| SMT201500005B (it) | Composizione framaceutica inalabile | |
| FR2953410B1 (fr) | Compositions antivirales pharmaceutiques ou veterinaires | |
| ZA201108458B (en) | Nitrile derivatives and their pharmaceutical use and compositions | |
| FR2958166B1 (fr) | Compositions pharmaceutiques fortement dosees en biotine | |
| BR112015002646A2 (pt) | composto e composição farmacêutica | |
| BR112013014606A2 (pt) | composições farmacêuticas compreendendo alisporivir, seu uso, e cápsula | |
| EP2635307A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
| CO6990712A2 (es) | Combinación farmacéutica antineuritica y composiciones |